A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
In a discussion with Oprah, Dr Ania called obesity a disease. She also advised that we should treat obesity like other ...
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...
“I’m making money to afford semagultide,” Rice, 42, who works three jobs to afford the expensive injectables, explained to her over 14,000 TikTok fans . Classified as a GLP-1, appetite-suppressing ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback